KingMed Diagnostics

Explore the latest insights on KingMed Diagnostics and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of KingMed Diagnostics’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.Explore the latest insights on KingMed Diagnostics and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of KingMed Diagnostics's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer's Disease Diagnosis and Treatment
CompanyDeals

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer’s Disease Diagnosis and Treatment

Eisai Co., Ltd. (TYO: 4523) and Siemens Healthineers AG (ETR: SHL) officially signed a strategic cooperation agreement during the 9th China International Import Expo (CIIE). The two parties announced that…

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation
CompanyDeals

GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation

AI in Healthcare: Accelerating Applications in Diagnostics and Multi-omics Analysis
Company

AI in Healthcare: Accelerating Applications in Diagnostics and Multi-omics Analysis

Wuhan Union Hospital to Transfer Hereditary Thrombophilia Detection Patent to Kingmed Diagnostics
CompanyDeals

Wuhan Union Hospital to Transfer Hereditary Thrombophilia Detection Patent to Kingmed Diagnostics

CompanyDeals

Sun Yat-sen University and KingMed Diagnostics Collaborate on Talent Development and Research

CompanyDeals

Kingmed Diagnostics Partners with GenStar Biosolutions to Develop Auto-Antibody Immunofluorescence AI Software

CompanyDeals

Kingmed Diagnostics and MegaRobo Technologies Join Forces to Pioneer Smart Medical Laboratories